Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia

American Journal of Psychiatry

Volumn 157, Issue 10, 2000, Pages 1646-1651

  Callicott, J H ^a   Bertolino, A ^a   Egan, M F ^a   Mattay, V S ^a   Langheim, F J P ^a   Weinberger, D R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA;

ADULT; ASPARTIC ACID; BRAIN; BRAIN CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0033802818     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.10.1646     Document Type: Article

References (70)

1. Improvement of negative symptoms: Concepts, definition and assessment
2. The profiles of clinical deterioration in schizophrenia
3. The natural history and pathophysiology of treatment resistant schizophrenia
4. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia
5. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia
6. Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies
7. The effects of cerebral lesions on intellectual function: A review of current research trends
8. Reactions of patients with focal cerebral lesions to success or failure
9. Structural abnormalities in the frontal system in schizophrenia: A magnetic resonance imaging study
10. Implications of normal brain development for the pathogenesis of schizophrenia
11. Functional and anatomical aspects of prefrontal pathology in schizophrenia
12. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: Assessment with Xenon 133 single-photon emission computed tomography and the Tower of London
13. Magnetic resonance imaging of the brain in schizophrenia: The pathophysiologic significance of structural abnormalities
14. Grey matter correlates of syndromes in schizophrenia: A semi-automated analysis of structural magnetic resonance images
15. Clinical subtypes of schizophrenia: Differences in brain and CSF volume
16. A follow-up magnetic resonance imaging study of schizophrenia: Relationship of neuroanatomical changes to clinical and neurobehavioral measures
17. Midsagittal cortical pathomorphology of schizophrenia: A magnetic resonance imaging study
18. Structural abnormalities in deficit and nondeficit schizophrenia
19. Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptoms and clinical subtype
20. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia
21. Sex differences in neuroanatomical and clinical correlations in schizophrenia
22. A card sorting test helpful in establishing prognosis
23. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia
24. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test
25. Schizophrenics show spatial working memory deficits
26. Visuospatial working memory in patients with schizophrenia
27. Working memory dysfunction in schizophrenia
28. Word and tone working memory deficits in schizophrenia
29. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients
30. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: Spatial working memory in patients with schizophrenia
31. Regional cerebral blood flow in patients with schizophrenia: A preliminary report
32. Patterns of cerebral blood flow in schizophrenia
33. Clinical symptoms and regional cerebral blood flow in schizophrenia
34. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study
35. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics
36. Eye-tracking patterns in schizophrenia
37. Differential EEG patterns in affective disorder and schizophrenia
38. Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients
39. Prefrontal function in schizophrenia: Confounds and controversies
40. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production
41. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test - A functional MRI study on healthy volunteers and schizophrenics
42. Functional magnetic resonance imaging brain mapping in psychiatry: Methodological issues illustrated in a study of working memory in schizophrenia
43. Functional hypofrontality and working memory dysfunction in schizophrenia
44. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging
45. The reduced neuropil hypothesis: A circuit based model of schizophrenia
46. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia
47. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
48. Altered distribution of nicotinamide-adenine dinucleotide phosphate diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development
49. Proton magnetic resonance spectroscopy in schizophrenia
50. Multisection proton MR spectroscopic imaging of the brain
51. The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations
52. The Psychiatric Symptom Assessment Scale
53. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging
54. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study
55. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging
56. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia
57. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
58. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain
59. N-Acetylaspartate in neuropsychiatric disorders
60. The effect of N-acetylaspartate on the intracellular calcium concentration in NTera2-neurons
61. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: Evidence from proton MR spectroscopic imaging
62. Chemical pathology of acute demyelinating lesions and its correlations with disability
63. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy
64. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure
65. Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease
66. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia
67. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
68. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
69. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited